Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
A. Singh, A. Miranda Bedate, H. J. Von Richthofen…·L. Meyaard
The paper introduces a bioinformatics pipeline to identify known and putative immune inhibitory receptors as therapeutic targets using machine learning and transcriptomics data.
H. J. von Richthofen, F. M. J. Hafkamp, A. van Haperen…·L. Meyaard
This study shows VSTM1-v2 does not enhance DC-driven or cytokine-driven Th17 cell differentiation in human naive CD4+ T cells.
H. J. von Richthofen, G. H. A. Westerlaken, D. Gollnast…·L. Meyaard
The paper shows that activated neutrophils release soluble SIRL-1 via proteinase 3 cleavage, and that sSIRL-1 is present in vivo in RSV and COVID-19 patients.
M. Rumpret, H. J. von Richthofen, M. van der Linden…·L. Meyaard
This study identifies S100 proteins as ligands for the inhibitory receptor SIRL-1, showing that SIRL-1 suppresses neutrophil ROS production via binding to S100A6.